Access to vital information is critical to health-systems management. The Pharma Report Database is a powerful decision support platform that provides you with abundant data and tools to help your health-system manage your product supply chain. Why spend days looking for information on a drug shortage, when The Pharma Report Database can give you information in seconds?
Don’t have The Pharma Report Database™?
Click here to find your solution.
Inventory analysis – Launch
Upload a list of NDCs as a text file, and we will instantly match each one with relevant product and shortage data. Identify your products that are at risk of becoming unavailable. Include inventory count and actual usage rate, and the tool will calculate days inventory on hand. With this information, you can identify the products in your supply chain that warrant added consideration and planning. Available with the Drug Shortage Database
Shortages are a growing burden on hospitals and other health systems. Manage your shortages better with The Pharma Report Professional Service. In seconds, you will find the information you need to manage a shortage. Dig into the root cause of the problem and find alternative sources for unavailable products. Updated daily.
Resolved drug shortages - search
You also need to know when shortages are resolved so that your health-system can update its response. The Pharma Report Shortages Database provides this information with the click of a button. Find teh information you need in seconds. Updated daily.
Drug to be discontinued – search
When a manufacturer chooses to stop producing a product, it can lead to supply disruptions, especially when there are few or no other manufacturers for the same product. By keeping an eye on these decisions, you can better anticipate shortages, and plan ahead. Updated daily.
Need more information on a drug product? Search the National Drug Code Directory through The Pharma Report Database, to look up information on nearly any drug product. Our instant reporting tools make it easy to share, save or print your results.
Drug firm registration status – search
Quickly find information on drug firms registered with the FDA, inside the US and abroad. Our easy search tools allow you to find company information in seconds.
Orange Book – search
Search the Orange Book through The Pharma Report Database. Quickly find information on therapeutic alternatives, rather than referring to the standard pdf document. The Pharma Report Database quickly finds the information you request, generates instant reports and, of course, you can save, share and print those reports.
Patents and exclusivity – search patents – search exclusivity
Find patent and exclusivity information for any drug product. This is a valuable resource for investors who want to know when a target company’s patents are expiring. A company’s patent portfolio can be its chief asset in the marketplace.
Clinical Trials (US) – search
Information and results for over 160,000 trials registered on clinicaltrials.gov, the United States’ registry for clinical trials. Includes ongoing and previous trials. Updated daily.
Clinical Trials (EU) – search
Over 22,000 trials registered on clinicaltrialsregister.eu, run by the European Medicines Agency (EMA). Study data are submitted by national agencies.
Bioresearch Monitoring Information System (BMIS) – search
Includes clinical investigators, contract research organizations, and institutional review boards involved in the conduct of Investigational New Drug (IND) studies with human investigational drugs and therapeutic biologics. Includes investigators engaged in research of CDER-regulated drugs and biologics under an IND, for whom FDA has received a Form FDA 1572. BMIS is not intended to provide a comprehensive list of all clinical investigators, CROs or IRBs involved in CDER-regulated clinical research.
Clinical Investigator Inspection List (CLIIL) – search
The Clinical Investigator Inspection List (CLIIL) contains names, addresses, and other pertinent information gathered from inspections of clinical investigators who have performed studies with investigational new drugs. The list contains information on inspections that have been closed since July 1977.